These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Synthesis and activity of a novel series of 3-biarylquinuclidine squalene synthase inhibitors. Brown GR; Clarke DS; Foubister AJ; Freeman S; Harrison PJ; Johnson MC; Mallion KB; McCormick J; McTaggart F; Reid AC; Smith GJ; Taylor MJ J Med Chem; 1996 Jul; 39(15):2971-9. PubMed ID: 8709131 [TBL] [Abstract][Full Text] [Related]
43. Synthesis and biological activity of methanesulfonamide pyrimidine- and N-methanesulfonyl pyrrole-substituted 3,5-dihydroxy-6-heptenoates, a novel series of HMG-CoA reductase inhibitors. Watanabe M; Koike H; Ishiba T; Okada T; Seo S; Hirai K Bioorg Med Chem; 1997 Feb; 5(2):437-44. PubMed ID: 9061208 [TBL] [Abstract][Full Text] [Related]
44. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Alberts AW; Chen J; Kuron G; Hunt V; Huff J; Hoffman C; Rothrock J; Lopez M; Joshua H; Harris E; Patchett A; Monaghan R; Currie S; Stapley E; Albers-Schonberg G; Hensens O; Hirshfield J; Hoogsteen K; Liesch J; Springer J Proc Natl Acad Sci U S A; 1980 Jul; 77(7):3957-61. PubMed ID: 6933445 [TBL] [Abstract][Full Text] [Related]
46. Effects of 32-oxygenated lanosterol derivatives on 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol biosynthesis from 24,25-dihydrolanosterol. Sonoda Y; Obi N; Onoda M; Sakakibara Y; Sato Y Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2796-9. PubMed ID: 1464112 [TBL] [Abstract][Full Text] [Related]
47. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 9. The synthesis and biological evaluation of novel simvastatin analogs. Hartman GD; Halczenko W; Duggan ME; Imagire JS; Smith RL; Pitzenberger SM; Fitzpatrick SL; Alberts AW; Bostedor R; Chao YS J Med Chem; 1992 Oct; 35(21):3813-21. PubMed ID: 1433193 [TBL] [Abstract][Full Text] [Related]
48. Colchicine inhibits hepatic cholesterol synthesis and microsomal 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA reductase) activity. Ottery FD; Goldfarb S FEBS Lett; 1976 May; 64(2):346-9. PubMed ID: 179885 [No Abstract] [Full Text] [Related]
49. Fatty acyl-CoA inhibition of beta-hydroxy-beta-methylglutaryl-CoA reductase activity. Faas FH; Carter WJ; Wynn JO Biochim Biophys Acta; 1978 Nov; 531(2):158-66. PubMed ID: 718968 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of 3-hydroxy-3-methylglutaryl-CoA synthase and cholesterol biosynthesis by beta-lactone inhibitors and binding of these inhibitors to the enzyme. Greenspan MD; Bull HG; Yudkovitz JB; Hanf DP; Alberts AW Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):889-95. PubMed ID: 8094614 [TBL] [Abstract][Full Text] [Related]
51. A comparison of the effects of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors on the CYP3A4-dependent oxidation of mexazolam in vitro. Ishigami M; Honda T; Takasaki W; Ikeda T; Komai T; Ito K; Sugiyama Y Drug Metab Dispos; 2001 Mar; 29(3):282-8. PubMed ID: 11181496 [TBL] [Abstract][Full Text] [Related]
52. Sex difference in inhibition of in vitro mexazolam metabolism by various 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors in rat liver microsomes. Ishigami M; Takasaki W; Ikeda T; Komai T; Ito K; Sugiyama Y Drug Metab Dispos; 2002 Aug; 30(8):904-10. PubMed ID: 12124308 [TBL] [Abstract][Full Text] [Related]
53. Hypocholesterolemic agents V: Inhibition of beta-hydroxy-beta-methylglutaryl coenzyme A reductase by substituted 4-biphenylylalkyl carboxylic acids and methyl esters. Boots SG; Boots MR; Guyer KE; Marecki PE J Pharm Sci; 1976 Sep; 65(9):1374-80. PubMed ID: 966157 [TBL] [Abstract][Full Text] [Related]
54. On the mechanism of regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and of acyl coenzyme A:cholesterol acyltransferase by dietary fat. Mitropoulos KA; Venkatesan S; Balasubramaniam S Biochim Biophys Acta; 1980 Aug; 619(2):247-57. PubMed ID: 7407210 [TBL] [Abstract][Full Text] [Related]
55. Synthesis of arylnaphthalenyl derivatives: inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme a reductase. Mewshaw RE; Hild EK; Commons TJ; Strike DP Drug Des Deliv; 1988 Nov; 3(3):235-43. PubMed ID: 3255330 [TBL] [Abstract][Full Text] [Related]
56. A simple model for studies on the regulation of cholesterol synthesis using freshly isolated hepatocytes. Cighetti G; Galli G; Galli Kienle M Eur J Biochem; 1983 Jul; 133(3):573-8. PubMed ID: 6861742 [TBL] [Abstract][Full Text] [Related]
57. Discovery of pyrrole-based hepatoselective ligands as potent inhibitors of HMG-CoA reductase. Bratton LD; Auerbach B; Choi C; Dillon L; Hanselman JC; Larsen SD; Lu G; Olsen K; Pfefferkorn JA; Robertson A; Sekerke C; Trivedi BK; Unangst PC Bioorg Med Chem; 2007 Aug; 15(16):5576-89. PubMed ID: 17560788 [TBL] [Abstract][Full Text] [Related]
59. Effect of policosanol on the hepatic cholesterol biosynthesis of normocholesterolemic rats. Menendez R; Amor AM; Gonzalez RM; Fraga V; Mas R Biol Res; 1996; 29(2):253-7. PubMed ID: 9278716 [TBL] [Abstract][Full Text] [Related]
60. Effects of 15-oxa-32-vinyl-lanost-8-ene-3 beta,32 diol on the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and low density lipoprotein receptor in rat liver. Ness GC; Lopez D; Chambers CM; Zhao Z; Beach DL; Ko SS; Trzaskos JM Arch Biochem Biophys; 1998 Sep; 357(2):259-64. PubMed ID: 9735166 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]